MARIA REDONDO to Glucagon-Like Peptide 1
This is a "connection" page, showing publications MARIA REDONDO has written about Glucagon-Like Peptide 1.
Connection Strength
0.224
-
GLP-1 Receptor Agonist as Adjuvant Therapy in Type 1 Diabetes: No Apparent Benefit for Beta-Cell Function or Glycemia. J Clin Endocrinol Metab. 2020 08 01; 105(8).
Score: 0.174
-
Diabetes of Unclear Type in an Adolescent Boy With Multiple Islet-cell Autoantibody Positivity Successfully Managed With Glucagon-like Peptide-1 Receptor Agonist Alone: A Case Report. Can J Diabetes. 2023 Feb; 47(1):90-93.
Score: 0.050